Comparing Variants of the Cell-Penetrating Peptide sC18 to Design Peptide-Drug Conjugates
Herein, the design and synthesis of peptide-drug conjugates (PDCs) including different variants of the cell-penetrating peptide sC18 is presented. We first generated a series of novel sequence mutants of sC18 having either amino acid deletions and/or substitutions, and then tested their biological a...
Main Authors: | Joshua Grabeck, Tamara Lützenburg, Pia Frommelt, Ines Neundorf |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/19/6656 |
Similar Items
-
Cell-penetrating peptides as part of therapeutics used in cancer research
by: Martin Matijass, et al.
Published: (2021-06-01) -
Recent Advances and Trends in Chemical CPP–Drug Conjugation Techniques
by: Félix Gayraud, et al.
Published: (2021-03-01) -
Molecular Dynamics Simulations of Drug-Conjugated Cell-Penetrating Peptides
by: Márton Ivánczi, et al.
Published: (2023-09-01) -
Redesigning of Cell-Penetrating Peptides to Improve Their Efficacy as a Drug Delivery System
by: Ildikó Szabó, et al.
Published: (2022-04-01) -
Peptide-Drug Conjugates: A New Hope for Cancer Management
by: Vivek P. Chavda, et al.
Published: (2022-10-01)